The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
about
Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine PhysiciansEfficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulationDifferential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatranSpotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatranNonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversalChoosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to KnowPharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolismManagement of anticoagulant-related intracranial hemorrhage: an evidence-based review.New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplastyApproach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questionsInterrupting anticoagulation in patients with nonvalvular atrial fibrillation.Emergency reversal of dabigatran for emergency surgery.Efficacy and safety of the drugs used to reverse direct oral anticoagulants: a systematic review and meta-analysis.Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old AgentsThe Role of Renal Replacement Therapy in the Management of Pharmacologic Poisonings.Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.Oral anticoagulants and status of antidotes for the reversal of bleeding risk.New oral anticoagulant and antiplatelet agents for neurosurgeons.Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit.Severe haematuria of lower urinary tract origin with low dose dabigatran use in three Indian elderly patients: unresolved issues in the safety of novel oral anticoagulants.Italian intersociety consensus on DOAC use in internal medicine.
P2860
Q26746917-F66C7CB9-6F9F-483A-A087-73943A578D16Q26749141-290B824B-1224-49F8-B331-99BD8638E2DAQ26799710-B9F64A05-04F8-4249-A0AA-AC2D02FDC2DEQ28066262-693F56BC-B39E-4728-A736-7E0FF44C6E9DQ28071657-8BE2030E-E519-4DC6-8AFC-769E5946697CQ28074445-735BB1FF-8D50-40FD-97EB-B2AD44C2A182Q28087447-853B49C3-0275-48CC-B11F-F19FA4C0410CQ33750215-5ACDF305-AE0A-4947-B1C8-8F9B7200DFF3Q33891915-CEEABD9C-A880-448F-9374-6157A10B435EQ34666269-7422FF11-F6B9-426B-B9FC-DC4806DF07ABQ34688742-9397A7E2-1C34-4DAF-909D-4C8AD2FC40CCQ35578443-72C9D8E3-D9B8-44ED-B889-E2AA5FB790D0Q36321564-5144FEE7-0498-4EE0-BC0A-3E3D06E7CC44Q37495788-769B8227-ABF2-4EFC-95F6-29F362894AC8Q37500808-632BEC27-76E3-4B93-B57D-17F10269A5EFQ38101845-D87C64AD-9B24-4E1E-9830-857174988DFBQ38200587-D130FD17-07E4-41BF-9772-D1E9E8741CC6Q38239244-A5659F41-2014-4048-839F-3FE1484E3806Q38513891-7066905E-6D69-49E3-AE9D-7DE8F930C649Q38889501-4DE70B99-F3A3-4DBD-BE5E-D8AFB9C29ED1Q38975409-89EA44DC-0905-4E4D-964D-D6996CAF5781Q43198338-F0EE2300-E0CF-4C35-B5F4-07435EB0F222Q49739706-064BFCC8-F255-40D7-94E1-BDAD83B85D8AQ50896785-6070B359-4391-4E5C-A877-621694FBB4D2
P2860
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The acute management of haemor ...... patients receiving dabigatran.
@en
The acute management of haemor ...... patients receiving dabigatran.
@nl
type
label
The acute management of haemor ...... patients receiving dabigatran.
@en
The acute management of haemor ...... patients receiving dabigatran.
@nl
prefLabel
The acute management of haemor ...... patients receiving dabigatran.
@en
The acute management of haemor ...... patients receiving dabigatran.
@nl
P2093
P2860
P50
P921
P1476
The acute management of haemor ...... patients receiving dabigatran
@en
P2093
Gary Benson
Peter Rose
Rachel Rayment
Raza Alikhan
Scott Marshall
Sue Pavord
Trevor Baglin
P2860
P304
P356
10.1136/EMERMED-2012-201976
P407
P5008
P577
2013-02-22T00:00:00Z
2014-02-01T00:00:00Z